Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Sells MassArray Systems to Five Academic Institutions

NEW YORK, June 8 - Five academic research centers have purchased Sequenom's MassArray system for genotyping analysis, the company said Friday.


The University of Massachusetts Medical School, the University of Texas Health Science Center at Houston, Wake Forest University School of Medicine, and the Weizmann Institute of Science purchased MassArray systems for the first time, and Boston University School of Medicine purchased its second system, according to a statement. Sequenom, of San Diego, now has its MassArray technology installed at a total of 33 industry and academic sites.


Typically, a MassArray system costs between $400,000 and $1.1 million, depending on consumables, the company has said.


The MassArray system, first commercialized in early 2000, provides a platform for genotyping experiments without the use of fluorescence or other tagging techniques. Instead, the company's technology applies MALDI-TOF mass spectrometry directly to fragments of DNA to detect SNPs.      

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.